Elias Salfati1, Shuktika Nandkeolyar1, Stephen P Fortmann1, Stephen Sidney1, Mark A Hlatky1, Thomas Quertermous1, Alan S Go1, Carlos Iribarren1, David M Herrington1, Benjamin A Goldstein1, Themistocles L Assimes2. 1. From the Department of Medicine, Stanford University School of Medicine, CA (E.S., S.P.F., M.A.H., T.Q., B.A.G., T.L.A.); Ecole Doctorale B2T, IUH, Université Paris 7, Paris, France (E.S.); Medical College of Wisconsin, Milwaukee (S.N.); Kaiser Permanente Center for Health Research, Portland, OR (S.P.F.); Kaiser Permanente Division of Research, Oakland, CA (S.S., A.S.G., C.I.); Heart and Vascular Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC (D.M.H.); and Department of Biostatistics and Bioinformatics, Duke University, Durham, NC (B.A.G.). 2. From the Department of Medicine, Stanford University School of Medicine, CA (E.S., S.P.F., M.A.H., T.Q., B.A.G., T.L.A.); Ecole Doctorale B2T, IUH, Université Paris 7, Paris, France (E.S.); Medical College of Wisconsin, Milwaukee (S.N.); Kaiser Permanente Center for Health Research, Portland, OR (S.P.F.); Kaiser Permanente Division of Research, Oakland, CA (S.S., A.S.G., C.I.); Heart and Vascular Center of Excellence, Wake Forest School of Medicine, Winston-Salem, NC (D.M.H.); and Department of Biostatistics and Bioinformatics, Duke University, Durham, NC (B.A.G.). tassimes@stanford.edu.
Abstract
BACKGROUND: Recent genome-wide association studies have identified 49 single nucleotide polymorphisms associated with clinical coronary artery disease. The mechanism by which these loci influence risk remains largely unclear. METHODS AND RESULTS: We examined the association between a genetic risk score composed of high-risk alleles at the 49 single nucleotide polymorphisms and the degree of subclinical coronary atherosclerosis in 7798 participants from 6 studies stratified into 4 age groups at the time of assessment (15-34, 35-54, 55-74, and >75 years). Atherosclerosis was quantified by staining and direct visual inspection of the right coronary artery in the youngest group and by scanning for coronary artery calcification in the remaining groups. We defined cases as subjects within the top quartile of degree of atherosclerosis in 3 groups and as subjects with a coronary artery calcium score >0 in the fourth (35-54 years) where less than one quarter had any coronary artery calcium. In our meta-analysis of all strata, we found 1-SD increase in the genetic risk score increased the risk of advanced subclinical coronary atherosclerosis by 36% (P=8.3×10(-25)). This increase in risk was significant in all 4 age groups including the youngest group where atherosclerosis consisted primarily of raised lesions without macroscopic evidence of plaque rupture or thrombosis. Results were similar when we restricted the genetic risk score to 32 single nucleotide polymorphisms not associated with traditional risk factors or when we adjusted for traditional risk factors. CONCLUSIONS: A genetic risk score for clinical coronary artery disease is associated with advanced subclinical coronary atherosclerosis throughout the life-course. This association is apparent even at the earliest, uncomplicated stages of atherosclerosis.
BACKGROUND: Recent genome-wide association studies have identified 49 single nucleotide polymorphisms associated with clinical coronary artery disease. The mechanism by which these loci influence risk remains largely unclear. METHODS AND RESULTS: We examined the association between a genetic risk score composed of high-risk alleles at the 49 single nucleotide polymorphisms and the degree of subclinical coronary atherosclerosis in 7798 participants from 6 studies stratified into 4 age groups at the time of assessment (15-34, 35-54, 55-74, and >75 years). Atherosclerosis was quantified by staining and direct visual inspection of the right coronary artery in the youngest group and by scanning for coronary artery calcification in the remaining groups. We defined cases as subjects within the top quartile of degree of atherosclerosis in 3 groups and as subjects with a coronary artery calcium score >0 in the fourth (35-54 years) where less than one quarter had any coronary artery calcium. In our meta-analysis of all strata, we found 1-SD increase in the genetic risk score increased the risk of advanced subclinical coronary atherosclerosis by 36% (P=8.3×10(-25)). This increase in risk was significant in all 4 age groups including the youngest group where atherosclerosis consisted primarily of raised lesions without macroscopic evidence of plaque rupture or thrombosis. Results were similar when we restricted the genetic risk score to 32 single nucleotide polymorphisms not associated with traditional risk factors or when we adjusted for traditional risk factors. CONCLUSIONS: A genetic risk score for clinical coronary artery disease is associated with advanced subclinical coronary atherosclerosis throughout the life-course. This association is apparent even at the earliest, uncomplicated stages of atherosclerosis.
Authors: Z Chen; A C Karaplis; S L Ackerman; I P Pogribny; S Melnyk; S Lussier-Cacan; M F Chen; A Pai; S W John; R S Smith; T Bottiglieri; P Bagley; J Selhub; M A Rudnicki; S J James; R Rozen Journal: Hum Mol Genet Date: 2001-03-01 Impact factor: 6.150
Authors: Wolfgang Lieb; Henning Jansen; Christina Loley; Michael J Pencina; Christopher P Nelson; Christopher Newton-Cheh; Sekar Kathiresan; Muredach P Reilly; Themistocles L Assimes; Eric Boerwinkle; Alistair S Hall; Christian Hengstenberg; Reijo Laaksonen; Ruth McPherson; Unnur Thorsteinsdottir; Andreas Ziegler; Annette Peters; John R Thompson; Inke R König; Jeanette Erdmann; Nilesh J Samani; Ramachandran S Vasan; Heribert Schunkert Journal: Hypertension Date: 2013-03-11 Impact factor: 10.190
Authors: Themistocles L Assimes; Joshua W Knowles; Analabha Basu; Carlos Iribarren; Audrey Southwick; Hua Tang; Devin Absher; Jun Li; Joan M Fair; Geoffrey D Rubin; Stephen Sidney; Stephen P Fortmann; Alan S Go; Mark A Hlatky; Richard M Myers; Neil Risch; Thomas Quertermous Journal: Hum Mol Genet Date: 2008-04-28 Impact factor: 6.150
Authors: Catherine Tcheandjieu; Xiang Zhu; Austin T Hilliard; Shoa L Clarke; Valerio Napolioni; Shining Ma; Kyung Min Lee; Huaying Fang; Fei Chen; Yingchang Lu; Noah L Tsao; Sridharan Raghavan; Satoshi Koyama; Bryan R Gorman; Marijana Vujkovic; Derek Klarin; Michael G Levin; Nasa Sinnott-Armstrong; Genevieve L Wojcik; Mary E Plomondon; Thomas M Maddox; Stephen W Waldo; Alexander G Bick; Saiju Pyarajan; Jie Huang; Rebecca Song; Yuk-Lam Ho; Steven Buyske; Charles Kooperberg; Jeffrey Haessler; Ruth J F Loos; Ron Do; Marie Verbanck; Kumardeep Chaudhary; Kari E North; Christy L Avery; Mariaelisa Graff; Christopher A Haiman; Loïc Le Marchand; Lynne R Wilkens; Joshua C Bis; Hampton Leonard; Botong Shen; Leslie A Lange; Ayush Giri; Ozan Dikilitas; Iftikhar J Kullo; Ian B Stanaway; Gail P Jarvik; Adam S Gordon; Scott Hebbring; Bahram Namjou; Kenneth M Kaufman; Kaoru Ito; Kazuyoshi Ishigaki; Yoichiro Kamatani; Shefali S Verma; Marylyn D Ritchie; Rachel L Kember; Aris Baras; Luca A Lotta; Sekar Kathiresan; Elizabeth R Hauser; Donald R Miller; Jennifer S Lee; Danish Saleheen; Peter D Reaven; Kelly Cho; J Michael Gaziano; Pradeep Natarajan; Jennifer E Huffman; Benjamin F Voight; Daniel J Rader; Kyong-Mi Chang; Julie A Lynch; Scott M Damrauer; Peter W F Wilson; Hua Tang; Yan V Sun; Philip S Tsao; Christopher J O'Donnell; Themistocles L Assimes Journal: Nat Med Date: 2022-08-01 Impact factor: 87.241
Authors: Bartłomiej Kisiel; Robert Kruszewski; Aleksandra Juszkiewicz; Anna Raczkiewicz; Artur Bachta; Krzysztof Kłos; Krzysztof Duda; Artur Maliborski; Konrad Szymański; Rafał Płoski; Marek Saracyn; Stanisław Niemczyk; Katarzyna Kisiel; Małgorzata Tłustochowicz; Witold Tłustochowicz Journal: Rheumatol Int Date: 2018-10-29 Impact factor: 2.631
Authors: Lauren M Severance; Francisco J Contijoch; Hannah Carter; Chun C Fan; Tyler M Seibert; Anders M Dale; Elliot R McVeigh Journal: J Cardiovasc Comput Tomogr Date: 2019-05-09